First PI3K inhibitor for breast cancer approved by FDA
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
List view / Grid view
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
The connected laboratory is now the only way forward, as the three days of the LABVOLUTION show have clearly demonstrated. Decision-makers, product developers and users from the various segments of the laboratory industry gathered in Hannover for a close look at the latest developments and future trends.
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
FDA sends warning to Petra Hygienic Systems Int LTD after they find violations of current good manufacturing practices (cGMPs).
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
Particle Measuring Systems releases the new Pharmaceutical Net® Pro Environmental Monitoring Software for FacilityPro® Environmental Monitoring Systems.
The first platform to facilitate the licensed importation of medical cannabis into Europe has formally launched in the UK.
Connect 2 Cleanrooms (C2C) and Elis Cleanroom have signed a partnership agreement on 18 May to further strengthen the contamination control solution packages offered to their customers.
New research shows that there is hardly any robust data from studies available on blister packaging for nursing homes.
Research shows that the NHS continues to provide the optimum environment for the life sciences industry to deliver research.
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
Pharmaceutical manufacturers and wholesale distributors could start losing billions of dollars because of faulty barcode scans.